Phospholipid‐Like Prodrug Liposomes with High Drug‐carrier Affinity and High Tumor Selectivity: Strong Competitors of Paclitaxel Nanomedicines

Journal:

Advanced Functional Materials

Published:

2025-07-11

DOI:

10.1002/adfm.202502341

Affiliations:

7

Authors:

16

Go to article

Institutions	Authors	Share
Shenyang Pharmaceutical University (SPU), China	13.500000 13.500000	0.84
Peking University Third Hospital (PUTH), PKUHSC, China	1.000000	0.06
First Affiliated Hospital of Jinzhou Medical University, China	1.000000	0.06
The University of Adelaide (Adelaide Uni), Australia	0.500000	0.03

Interested in Pharmacology and Pharmaceutical Sciences?